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Zusammenfassung
Hintergrund: Das Mammakarzinom ist die häufigste 
Krebsart bei Frauen mit einer jährlichen Prävalenz-
zunahme von 2%. Verschiedene Studien haben sich mit 
der Bestimmung modifizierbarer Risikofaktoren befasst. 
Ziel der vorliegenden Studie war es, Brustkrebs-Risiko-
faktoren bei Frauen in der Golestan-Provinz zu bestim-
men. Patienten und Methoden: Diese Fallkontrollstudie 
wurde mit Brustkrebspatientinnen, die zwischen 2004 
und 2006 im Krebsregister aufgenommen worden waren 
(n = 134) sowie deren altersentsprechenden Nachbarn 
(n = 133) durchgeführt. Die Daten wurden statistisch ana-
lysiert. Ergebnisse: Weder das Alter zum Zeitpunkt der 
Heirat, Menarche und Schwangerschaft, das Stillverhal-
ten, eine positive Familienvorgeschichte, der Ehestand 
noch der Bildungsstand waren signifikant mit dem Brust-
krebsrisiko korreliert. Das Alter bei Einsatz der Meno-
pause (<46,6 Jahre) war dagegen signifikant korreliert 
(95% Konfidenzinterval 1,15–7,37; p = 0,021). Bei Lebend-
geburten, Totgeburten und Kindstod bestanden keine 
 signifikanten Unterschiede zwischen den beiden Grup-
pen. Für andere Variablen wie beispielsweise dem 
 Raucherstatus wurde keine Odds-Ratio berechnet. 
Schlussfolgerung: Die Ergebnisse zeigen, dass keine 
 signifikante Korrelation zwischen den Variablen und dem 
Brustkrebsrisiko in der von uns untersuchten Population 
besteht. Die einzige Ausnahme bildet das Alter bei Ein-
satz der Menopause. Eine größere Kohortenstudie ist 
empfehlenswert.
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Summary
Background: Breast cancer is the most common cancer 
in women. Its prevalence is increasing annually by 2%. 
The determination of modifiable risk factors has been 
the subject of various studies. The aim of this study was 
to determine risk factors of breast cancer in women in 
Golestan Province. Patients and Methods: This case-con-
trol study was conducted among women with breast 
cancer recorded in the cancer registry system between 
2004 and 2006 (n = 134), and their age-matched healthy 
neighbors (n = 133). Data were statistically analyzed. 
 Results: Age at marriage, menarche and pregnancy, 
breast feeding, positive family history, marital status, 
and educational level were not significantly correlated 
with risk of breast cancer, but age at menopause (< 46.6 
years) was significantly correlated (95% confidence inter-
val 1.15–7.37; p = 0.021). Live births, still births, and 
 infant deaths were not significantly different between 
the 2 groups. For other variables, such as smoking his-
tory, no odds ratio was calculated. Conclusion: Results 
show that there is no significant correlation between 
variables and risk of breast cancer in our population, 
 except for age at menopause. A large cohort study is 
recommended.
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graphic data such as age, residency, ethnicity, marital status, profession, 
educational level, and risk factors which were discussed in previous stud-
ies such as age at menarche, menopause and first pregnancy, number of 
children, and number of abortions. The coded data were entered into a 
computer and analyzed using SPSS-13 (SPSS Inc., Chicago, IL, USA); 
statistical tests included chi square and independent t-test as well as non-
parametric tests; 95% confidence interval and odds ratio (OR) were 
calculated.
Results
Of the registered cases, 52 were dead and 162 could not be 
found for various reasons; 134 cases and 133 controls were en-
rolled. The mean age was 47.15 ± 10.36 years (cases) and 42.96 
± 11.93 years (controls). All demographic data and risk fac-
tors addressed in the questionnaire are reported in table 1. 
Those factors which had a p value of less than 0.2 were in-
Introduction
Breast cancer is the most prevalent cancer in women world-
wide, with an annual increase in prevalence of about 2%. In 
2000, the breast cancer incidence increased to 1 in 8 women. 
In the 7th decade of life, it will affect 1 in 13 American 
women, and in the 8th decade 1 in 11 women [1, 2]. There are 
significant variations between geographic areas with regard to 
breast cancer incidence [3]. Over the next decade, as women 
adapt to western lifestyles by marrying and bearing children 
later in life, developing countries may face a potential breast 
cancer epidemic [3], and due to these lifestyle changes and the 
lack of resources to create mass awareness and provide early 
detection, the incidence is increasing across countries with 
lower health care facilities. Iran is amongst the medium prev-
alence countries, but its incidence and prevalence are increas-
ing [4]. Similar to other developing countries, the mean age-
specific incidence of patients in Iran is 10–20 years less than 
other countries (approximately 47 years) [5]. Iran is estimated 
to face a serious breast cancer burden in the coming years.
As the Golestan cancer registry shows, breast cancer is the 
3rd most common cancer in our province, after esophageal 
and stomach cancers, with an age standardized rate of 13.5 
per 100,000 [6]. Considering the incidence and prevalence of 
breast cancer, the high cost of treatment, and the young age at 
disease onset, it is important to urge governments to aggres-
sively schedule strategies for early detection such as providing 
mammography machines in health care facilities and hospitals 
[3, 7]. Several risk factors are considered for breast cancer 
some of which are confirmed, while others are controversial 
and may be rejected. In Iran, few studies about breast cancer 
risk factors exist. This study was designed to detect the risk 
factors for the Golestan Province, Northeast Iran.
Patients and Methods
This case-control study included all patients who were registered as hav-
ing breast cancer between 2004 and 2006. Age-matched neighbors were 
used as controls. Names and addresses were derived from the cancer reg-
istry system of Golestan Province. The database contained 300 registered 
cases some of which were repeated and therefore deleted from the list, 
some addresses were incomplete, and others had moved to a different lo-
cation, leaving a total of 134 cases. The population-based cancer registry 
gathers data relating to cancer patients of all pathologies from laborato-
ries, hospitals, local health offices, clinics, and physician offices. However, 
despite strong recommendations by the coordinator, personnel who fill in 
the forms frequently fail to write down a complete and straight forward 
home address, which causes limitations for our kind of study. Further-
more, due to the lack of community-wide screening programs and no spe-
cific attention being paid to routine simple screening tests, patients are 
usually referred at high stages of cancer. We used trained personnel from 
the Golestan Health Network to complete valid and reliable question-
naires through interview. Patients who had passed away were excluded 
and no control was considered for them. One supervisor controlled all 
questionnaires of a particular district and posted the completed forms to 
the main office of the Health Deputy. The questionnaire included demo-
Table 1. Distribution of demographic data and risk factors in breast 
 cancer cases and controls
Cases, n (%) Controls, n 
(%)
p
Residence 0.896
Urban  81 (63.77)  82 (64.56)
Rural  46 (36.22)  45 (35.43)
Total 127 (100) 127 (100)
Ethnicity 0.636
Turkmen  31 (27.19)  31 (30.09)
Fars  83 (72.8)  72 (69.9)
Total 114 (100) 103 (100)
Marriage 0.702
Single   4 (3.14)   3 (2.36)
Married 123 (96.85) 124 (97.63)
Total 127 (100) 127 (100)
Professional status 0.719
Housewife 108 (85.03) 110 (86.61)
Professional  19 (14.96)  17 (13.38)
Total 127 (100) 127 (100)
Educational level 0.594
Illiterate 101 (79.5)  97 (76.37)
Educated  26 (20.47)  30 (23.62)
Total 127 (100) 127 (100)
Contraception 0.163
Oral contraceptives  47 (50.53)  41 (36.28)
Other  46 (49.46)  72 (63.71)
Total  93 (100) 113 (100)
History of infertility 18 8 0.03
History of abortion 38 38 0.78
History of stillbirth 10 6 0.27
Hormone replacement 
therapy
1 3 0.34
History of cancer in 
 first-degree relatives
23 12 0.04
History of cancer in 
 second-degree relatives
13 9 0.37
History of cancer in the  
patient her/himself
10 0 0.002
History of benign lesions  
in the breast
9 2 0.06
History of radiation to  
head/neck and chest
22 4 0.78
Breast Care 2011;6:453–456Breast Cancer Risk Factors 455
cluded into the regression analysis. As shown in table 2, after 
univariate and multivariate regression analysis, the most 
 important risk factor associated with risk of breast cancer 
was age at marriage. The mean age at marriage was signifi-
cantly higher in cases than in controls, in both univariate and 
multivariate analysis. The mean age at menarche was not sig-
nificantly different between cases and controls (p = 0.593) 
(table 3). Results indicate that the mean age at menopause 
was less in the case group than in the control group (p = 0.04), 
but in multivariate analysis no significant relationship was 
seen. Mean age at first pregnancy was not significantly differ-
ent between cases and controls (table 3) (p = 0.77). No differ-
ence was seen between the 2 groups with regard to live births, 
live children, history of still births, and death of children aged 
< 2 years (p > 0.05). No significant correlation was seen 
 between the risk of breast cancer and marriage status 
(p = 0.702), educational level less than diploma (p = 0.594), 
history of breast cancer in second-degree relatives (p = 0.37), 
and breast feeding. ORs were not calculated for smoking and 
other diseases due to the low amount of positive cases.
Discussion
Results show that the mean age of patients was 47.15 ± 10.36 
years, which is very similar to other studies in Iran and other 
countries [8–13]. In our study, there was no significant corre-
lation between age at marriage and risk of breast cancer. In 
another study carried out in Shiraz, a significant rise in the 
risk of breast cancer was seen when marriage occurred after 
25 years of age [14]. Maybe sexual activity and its effect on 
sex hormone secretion play a role here. In the present study, 
significant correlation was seen between breast cancer and 
menarche occurring before 13.37 years of age and menopause 
before 46.6 years of age [8, 14]. However, another study 
showed an OR = 0.72 for menarche after 17 years of age [15], 
and others even showed a protective role of late-age me-
narche [16]. It has been said that a lower age at menarche and 
a higher age at menopause can influence the risk of develop-
ing breast cancer [17, 18]. Maybe the fact that hormone re-
placement therapy is not used in our area plays a role in the 
present results [2, 19]. The results also show an increase in the 
risk of breast cancer in women who deliver their first child at 
age less than 20.51 years (not significant). Numerous studies 
indicated that age at first delivery can be a risk factor [8, 14, 
16, 17, 20]. Also, nulliparity and the total number of children 
have been reported as risk factors [17, 21, 22] but we did not 
find this in the present study. Others showed a protective ef-
fect of parity and breast feeding with a 7% decrease in breast 
cancer risk seen for every 12 months of breast feeding [15]. In 
the present study, breastfeeding for a total of > 64.35 months 
had an OR = 0.73. A protective effect of breastfeeding was 
reported before [22–25, 15, 18], although others reported no 
protective effect [26]. In our area, no significant correlation 
was seen between risk of breast cancer and marriage. This was 
similar to other studies [20, 14, 27], but some authors have re-
ported a higher risk for married women [10]. Some interfering 
variables like oral contraceptives can be included here. No 
significant relationship was seen with regard to lower educa-
tional levels and family history of breast cancer, but the latter 
was reported to be a risk factor in other reports [8, 9, 18]. 
Here, we only saw a significant correlation between risk of 
breast cancer and lower age at menopause (which was not 
confirmed in multivariate analysis).
Breast cancer development is a multifactorial process 
which includes a complex interaction between physical activ-
ity, diet, energy intake, and body weight. This suggests that 
continual updating of knowledge on primary prevention and 
identification of behavioral changes will reduce the risk [23]. 
Thus, prevention strategies in our area could include avoid-
ance of modifiable risk factors such as late first pregnancy, ab-
sence or short duration of breast feeding, and use of hormone 
replacement therapy in postmenopausal women which is en-
couraged in some studies. Our findings have highlighted the 
heterogeneity of breast cancer etiology across populations 
and indicated the need for further studies. The most interest-
Univariate analysis, 
crude OR (CI 95%)
Multivariate 
 analysis, adjusted 
OR (CI 95%)
History of infertility 2.54 (1.06–6.08) 0.48 (0.1–2.29)
History of cancer in first-degree relatives 2.12 (1.01–4.47) 1.07 (0.22–5.24)
History of other cancers in the patient her/himself 1.09 (1.03–1.14) 0 (0.00–0.00)
History of benign lesion in the breast 4.73 (1.01–22.34) 0 (0.00–0.00)
History of radiotherapy to head/neck and chest 6.39 (2.14–19.17) 0.13 (0.01–1.26)
Age at marriage 1.07 (1.01–1.13) 1.17 (1.03–1.33)
Age at menopause 0.92 (0.84–0.99) 0.92 (0.84–1.01)
CI = Confidence interval.
Table 2. Odds ratio (OR) of different 
risk  factors by univariate and multivariate 
 regression analysis
Table 3. Comparison between cases and controls regarding age 
at marriage, menarche, menopause, and first pregnancy
Cases, mean ± SD
Controls, 
mean ± SD
p
Age at marriage 20.12 ± 5.11 18.45 ± 4.49 0.006
Age at menarche 13.13 ± 1.24 13.42 ± 1.42 0.593
Age at menopause 45.81 ± 6.04 48.31 ± 4.56 0.04
Age at first pregnancy 21.07 ± 5.02 21.56 ± 18.61 0.77
SD = Standard deviation.
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ing result of this study was the significant correlation between 
age at marriage and risk of breast cancer, which could be a 
modifiable risk factor, especially in our area. Also, treatment 
of infertility, planning for earlier detection of cancer in those 
with a positive history of breast cancer in first-degree relatives 
or in persons with a medical history of other cancers or benign 
lesions of the breast could be modifiable risk factors applica-
ble for this area and potentially helpful in the quest to change 
the pattern of breast cancer.
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